Chest physiotherapy with positive airway pressure: a pilot study of short-term effects on sputum clearance in patients with cystic fibrosis and severe airway obstruction
…, G Polese, L Zanolla, BM Assael, C Braggion - Respiratory …, 2006 - rc.rcjournal.com
BACKGROUND: The periodic administration of positive airway pressure combined with directed
cough could aid mucus clearance in patients with cystic fibrosis (CF) and severe airway …
cough could aid mucus clearance in patients with cystic fibrosis (CF) and severe airway …
[HTML][HTML] Serratia marcescens outbreak in a neonatal intensive care unit: crucial role of implementing hand hygiene among external consultants
…, L Lega, S Campana, KP Biermann, C Braggion… - BMC infectious …, 2015 - Springer
Background Serratia marcescens represents an important pathogen involved in hospital
acquired infections. Outbreaks are frequently reported and are difficult to eradicate. The aim of …
acquired infections. Outbreaks are frequently reported and are difficult to eradicate. The aim of …
Two CFTR mutations within codon 970 differently impact on the chloride channel functionality
…, E Vanderhelst, V Terlizzi, C Braggion… - Human …, 2019 - Wiley Online Library
Pharmacological rescue of mutant cystic fibrosis transmembrane conductance regulator (CFTR)
in cystic fibrosis (CF) depends on the specific defect caused by different mutation classes…
in cystic fibrosis (CF) depends on the specific defect caused by different mutation classes…
[HTML][HTML] Cystic fibrosis screen positive inconclusive diagnosis (CFSPID): Experience in Tuscany, Italy
…, R Buzzetti, C Centrone, L Zavataro, C Braggion - Journal of Cystic …, 2019 - Elsevier
Objective The implementation of cystic fibrosis (CF) newborn screening (NBS) has led to
identification of infants with a positive NBS test but inconclusive diagnosis classified as “CF …
identification of infants with a positive NBS test but inconclusive diagnosis classified as “CF …
[HTML][HTML] Methicillin-resistant Staphylococcus aureus eradication in cystic fibrosis patients: A randomized multicenter study
…, F Miselli, E Camera, L Zavataro, C Braggion… - PLoS …, 2019 - journals.plos.org
Background Few studies, based on a limited number of patients using non-uniform therapeutic
protocols, have analyzed Methicillin-resistant Staphylococcus aureus (MRSA) eradication…
protocols, have analyzed Methicillin-resistant Staphylococcus aureus (MRSA) eradication…
[HTML][HTML] Clinical expression of cystic fibrosis in a large cohort of Italian siblings
…, D Salvatore, A Angioni, A Bisogno, C Braggion… - BMC Pulmonary …, 2018 - Springer
Background A clinical heterogeneity was reported in patients with Cystic Fibrosis (CF) with
the same CFTR genotype and between siblings with CF. Methods We investigated all clinical …
the same CFTR genotype and between siblings with CF. Methods We investigated all clinical …
The prevalence of anxiety and depression in Italian patients with cystic fibrosis and their caregivers
…, C Risso, P Tabarini, C Braggion… - Pediatric …, 2016 - Wiley Online Library
Background: Cystic fibrosis, like other chronic diseases, is a risk factor for the development
of elevated symptoms of depression and anxiety. The objective of this study was to …
of elevated symptoms of depression and anxiety. The objective of this study was to …
[HTML][HTML] Trans-heterozygosity for mutations enhances the risk of recurrent/chronic pancreatitis in patients with Cystic Fibrosis
…, L Da Sacco, F Alghisi, A Angiolillo, C Braggion… - Molecular …, 2018 - Springer
Background Recurrent (RP) and chronic pancreatitis (CP) may complicate Cystic Fibrosis (CF).
It is still unknown if mutations in genes involved in the intrapancreatic activation of trypsin …
It is still unknown if mutations in genes involved in the intrapancreatic activation of trypsin …
Travel-Associated Burkholderia pseudomallei Infection (Melioidosis) in a Patient with Cystic Fibrosis: A Case Report
…, G Cazzola, A Petrucca, C Braggion - Clinical Infectious …, 2001 - academic.oup.com
In September 1997, a 25-year-old Italian woman with cystic fibrosis (CF) spent 3 weeks in
Thailand. In August 1998, her pulmonary function rapidly declined, with productive cough and …
Thailand. In August 1998, her pulmonary function rapidly declined, with productive cough and …
Effectivenesss of ivacaftor in severe cystic fibrosis patients and non‐G551D gating mutations
…, V Carnovale, P Iacotucci, C Braggion… - Pediatric …, 2019 - Wiley Online Library
Background Ivacaftor is a significant innovation in the treatment of cystic fibrosis (CF) with
gating mutations. A substantial percentage of patients with CF have severe lung involvement, …
gating mutations. A substantial percentage of patients with CF have severe lung involvement, …